“Revenue related to patient volumes and case mix were up some in Q1 2024, but were offset by rising expenses, including labor costs, seen across the country,” Montefiore said in a statement shared with Becker’s. “We remain steadfast in working with our elected partners across the state and federal government to ensure Medicaid reimbursements cover the cost of care, and that long-term sustainable funding continues to safeguard the highest quality care in the communities we serve.”
Montefiore’s total operating revenue was $2 billion for the three months ended March 31. That’s up from $1.9 billion posted over the same period last year. Net patient revenue was $1.9 billion, up from $1.7 billion in the same quarter in 2023.
Total operating expenses were $2 billion, up from $1.9 billion over the same period last year. Salaries and wages totaled $952.8 million, up from $843.4 million. Supplies and other expenses totaled $698.8 million in the quarter, up from $684 million last year.
The system posted a net loss of $5.3 million in the quarter, down from a net income of $62.6 million in the first quarter of 2023.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
